2023 annual financial data
ImmuCell 2023 Operating margin
ImmuCell 2023 operating margin with verified reported values.
Direct answer
Operating margin was -32.9%.
Operating income was -5,748,078 USD and net income was -5,774,598 USD.
Operating cash flow was -4,674,236 USD.
Get free ImmuCell email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 17,471,669 USD
- Operating income
- -5,748,078 USD
- Net income
- -5,774,598 USD
- Operating cash flow
- -4,674,236 USD